Cargando…
Immune-Mediated Cerebellar Ataxias: Clinical Diagnosis and Treatment Based on Immunological and Physiological Mechanisms
Since the first description of immune-mediated cerebellar ataxias (IMCAs) by Charcot in 1868, several milestones have been reached in our understanding of this group of neurological disorders. IMCAs have diverse etiologies, such as gluten ataxia, postinfectious cerebellitis, paraneoplastic cerebella...
Autores principales: | Mitoma, Hiroshi, Manto, Mario, Hadjivassiliou, Marios |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Movement Disorder Society
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7840241/ https://www.ncbi.nlm.nih.gov/pubmed/33423437 http://dx.doi.org/10.14802/jmd.20040 |
Ejemplares similares
-
Rare Etiologies in Immune-Mediated Cerebellar Ataxias: Diagnostic Challenges
por: Hadjivassiliou, Marios, et al.
Publicado: (2022) -
Guidelines for treatment of immune-mediated cerebellar ataxias
por: Mitoma, Hiroshi, et al.
Publicado: (2015) -
Diagnostic Criteria for Primary Autoimmune Cerebellar Ataxia—Guidelines from an International Task Force on Immune-Mediated Cerebellar Ataxias
por: Hadjivassiliou, Marios, et al.
Publicado: (2020) -
Immune-mediated cerebellar ataxias: from bench to bedside
por: Mitoma, Hiroshi, et al.
Publicado: (2017) -
Immune-mediated Cerebellar Ataxias: Practical Guidelines and Therapeutic Challenges
por: Mitoma, Hiroshi, et al.
Publicado: (2019)